Research & Analysis
We consult GIDEON whenever we detect a microorganism that has not been previously identified in our environmental monitoring.”
Sanja Popovic
Microbiology Environmental Monitoring Group Leader
Pliva Croatia
About Pliva Croatia
Pliva Croatia, a leading pharmaceutical manufacturer, has maintained a longstanding commitment to safety and quality.
For over a decade, their team has integrated GIDEON into their rigorous environmental monitoring (EM) protocols to navigate the complexities of microbial identification.
Strengthening environmental monitoring protocols
In the highly regulated world of pharmaceutical manufacturing, identifying a new or unexpected microorganism is a critical event.
For the team at Pliva, GIDEON is one of the key resources consulted when they identify a microorganism that was not previously identified in their environmental monitoring.
By utilizing GIDEON’s database, Pliva scientists can quickly pivot from detection to investigation, ensuring that new isolates are understood within the context of the global microbial landscape.
“We are primarily interested in the source of microorganisms and how an isolate can be related to the place of sampling in production (natural reservoir).”
A multi-faceted approach to microbial intelligence
Pliva maintains a comprehensive strategy where GIDEON serves as a specialized component of a broader global toolkit. By functioning as an initial point of reference, the platform provides the essential data needed to guide the next steps of a high-stakes investigation.
Layering GIDEON’s insights with specialized scientific literature and internal benchmarks helped Pliva’s experts maintain a truly comprehensive perspective.
This enduring partnership highlights how the GIDEON platform acts as a vital, integrated layer within the company’s overarching safety strategy, supporting a robust and rigorous microbial identification process.
For the team at Pliva Croatia, identifying a microorganism is only the initial step in a larger safety narrative. The critical value lies in understanding the “why” and “where” behind the detection.
GIDEON’s database on infectious disease outbreaks offers unparalleled insights.
GIDEON Advantages
Initial reference layer
GIDEON’s database contains in-depth phenotype information on over 3,000
bacteria, mycobacteria, and yeasts to guide the early stages of an investigation.
Bayesian analysis-driven pathogen identification toolkit
Microbiologists can utilize Bayesian analysis-based differential organism
identification to generate a prioritized and ranked pathogen probability list.
Dynamic comparison tables
Side-by-side comparison tables can be generated for up to 10 different
bacteria, mycobacteria, or yeasts at a time to highlight their distinguishing
characteristics.
Extensive collection of epidemiological surveys
The platform leverages over 130,000 prevalence and seroprevalence surveys to
help analysts understand the global distribution of specific pathogens.
Geographical context
GIDEON provides 27,000+ country-disease specific notes and interactive maps to identify endemic regions and potential natural reservoirs for isolates.
Daily expert-curated updates
The system is updated daily by a multidisciplinary team of medical scientists tracking over 20,000 global sources of data.